Publications by authors named "Yuji Tada"

Claim this Profile
P
Potential Utility of Combined Presepsin and LDH Tracking for Predicting Therapeutic Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Interstitial Lung Diseases: A Pilot Study.
Yuichiro Takeshita, Yasuo To, Masako To, Naho Furusho, Yusuke Kurosawa, Yuji Tada

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Small-Cell Lung Cancer With Novel Anaplastic Lymphoma Kinase Gene Rearrangement That Developed Intradural Extramedullary Spinal Metastases With Myelitis.
Yuri Mizuno, Yuji Tada, Taira Uehara, Satoshi Yamashita, Hiroyuki Murai

Cureus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of incidence of gastroesophageal reflux after lung resection.
Toshiko Kamata, Shigetoshi Yoshida, Yuji Tada, Tetsuo Sato

J Thorac Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Yuji Tada

Int J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of Combined Measurement of Surfactant Protein D, Thrombin-Antithrombin III Complex, D-Dimer, and Plasmin-α2 Plasmin Inhibitor Complex in Acute Exacerbation of Interstitial Lung Disease: A Retrospective Cohort Study.
Yuichiro Takeshita, Masako To, Yusuke Kurosawa, Naho Furusho, Toru Kinouchi, Yuji Tada

J Clin Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Outcomes of Ablative Carbon-Ion Radiotherapy for Central Non-Small Cell Lung Cancer: A Single-Center, Retrospective Study.
Shuri Aoki, Hitoshi Ishikawa, Mio Nakajima, Naoyoshi Yamamoto, Shinichiro Mori, Yuji Tada

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Single-Fraction Carbon-Ion Radiotherapy for Early-Stage Lung Cancer with Interstitial Pneumonia.
Shuri Aoki, Hitoshi Ishikawa, Mio Nakajima, Naoyoshi Yamamoto, Shinichiro Mori, Yuji Tada

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with predicted body weight-based dexamethasone, remdesivir, and baricitinib in patients with COVID-19 pneumonia: A single-center retrospective cohort study during 5th wave in Japan.
Yasutaka Hirasawa, Jiro Terada, Yu Shionoya, Atsushi Fujikawa, Yuri Isaka, Yuji Tada

Respir Investig· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between Anti-SARS-CoV-2 S Abs and IFN-λ3 Levels in the Administration of Oxygen following COVID-19 Vaccination.
Yuichiro Takeshita, Yasuo To, Yusuke Kurosawa, Toru Kinouchi, Kota Tsuya, Yuji Tada

Immunohorizons· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.
Toshio Suzuki, Jonathan A Kropski, Jingyuan Chen, Erica J Carrier, Xinping Chen, Yuji Tada

Am J Respir Crit Care Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel score model to predict hyperinflammation in COVID-19 as a forecast of optimal steroid administration timing.
Yuichiro Takeshita, Jiro Terada, Yasutaka Hirasawa, Taku Kinoshita, Hiroshi Tajima, Yuji Tada

Front Med (Lausanne)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trial.
Jiro Terada, Retsu Fujita, Takuya Kawahara, Yasutaka Hirasawa, Taku Kinoshita, Yuji Tada

EClinicalMedicine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia.
Yuri Isaka, Yasutaka Hirasawa, Jiro Terada, Yu Shionoya, Yuichiro Takeshita, Yuji Tada

Pulm Pharmacol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
Yuichiro Takeshita, Jiro Terada, Yasutaka Hirasawa, Taku Kinoshita, Hiroshi Tajima, Yuji Tada

Respir Investig· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients.
Yuichiro Takeshita, Jiro Terada, Yasutaka Hirasawa, Taku Kinoshita, Hiroshi Tajima, Yuji Tada

J Clin Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression.
Thao Thi Thanh Nguyen, Masato Shingyoji, Michiko Hanazono, Boya Zhong, Takao Morinaga, Yuji Tada

Cell Death Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study.
Yuichiro Takeshita, Jiro Terada, Retsu Fujita, Yasutaka Hirasawa, Taku Kinoshita, Yuji Tada

BMJ Open Respir Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.
Takashi Nakano, Kozo Kuribayashi, Masashi Kondo, Masahiro Morise, Yuji Tada

Asia Pac J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Trispirocyclotriphosphazenes with Oxaphosphorine Rings and Their Crystal and Molecular Structures.
Yuji Tada, Atsushi Sunada, Riki Watanabe, Makoto Kanazawa, Keiichiro Utsumi

Inorg Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective targeting of KRAS-driven lung tumorigenesis via unresolved ER stress.
Iwao Shimomura, Naoaki Watanabe, Tomofumi Yamamoto, Minami Kumazaki, Yuji Tada

JCI Insight· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a p53-activating CP-31398 and an MDM2 or a FAK inhibitor produces growth suppressive effects in mesothelioma with wild-type p53 genotype.
Boya Zhong, Masato Shingyoji, Michiko Hanazono, Thi Thanh Nguyễn, Takao Morinaga, Yuji Tada

Apoptosis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma.
Yuji Tada, Masatoshi Tagawa, Toshikazu Yusa, Mari Yatomi, Iwao Shimomura

SAGE Open Med Case Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy.
Kohei Shikano, Tsukasa Ishiwata, Fumie Saegusa, Jiro Terada, Masashi Sakayori, Yuji Tada

J Thorac Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes in structural lung abnormalities using MDCT in chronic obstructive pulmonary disease with asthma-like features.
Rie Anazawa, Naoko Kawata, Yukiko Matsuura, Jun Ikari, Yuji Tada

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilic bronchiolitis successfully treated with mepolizumab.
Yuichiro Takeshita, Seiichi Nobuyama, Yukiko Kanetsuna, Akihiko Tanaka, Mitsuru Adachi, Yuji Tada

J Allergy Clin Immunol Pract· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis